Washington Focus: Prescription Drug Advertising: In The Bull's Eye Again

Daniel L. Jaffe

Update on the ANA's continuing fight to free prescription drugs advertising from unnecessary regulation.

 Washington Focus

Prescription drug advertising: in the bull's eye again

Daniel L. Jaffe ANA

ANA fought a long and hard battle to remove outdated and counterproductive restrictions on prescription drug advertising to consumers. For years, the Food and Drug Administration (FDA) required so much disclosure in direct-to-consumer (DTC) drug advertising that the result was a de facto ban on the use of the broadcast media. The regulations also ensured that this type of advertising was of little use to consumers.

These restrictions, ANA pointed out, not only violated constitutional free speech protections, but also weakened the health care system...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands